BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 23665870)

  • 1. The role of inflammation in sporadic and familial Parkinson's disease.
    Deleidi M; Gasser T
    Cell Mol Life Sci; 2013 Nov; 70(22):4259-73. PubMed ID: 23665870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.
    Su X; Federoff HJ
    Biomed Res Int; 2014; 2014():275178. PubMed ID: 24822191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop.
    Arena G; Sharma K; Agyeah G; Krüger R; Grünewald A; Fitzgerald JC
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):427-440. PubMed ID: 35674870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.
    Burbulla LF; Krüger R
    J Neurol Sci; 2011 Jul; 306(1-2):1-8. PubMed ID: 21513949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
    Saponjic J; Mejías R; Nikolovski N; Dragic M; Canak A; Papoutsopoulou S; Gürsoy-Özdemir Y; Fladmark KE; Ntavaroukas P; Bayar Muluk N; Zeljkovic Jovanovic M; Fontán-Lozano Á; Comi C; Marino F
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 as a target for modulating immune system responses.
    Russo I; Bubacco L; Greggio E
    Neurobiol Dis; 2022 Jul; 169():105724. PubMed ID: 35427743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.
    Taylor JM; Main BS; Crack PJ
    Neurochem Int; 2013 Apr; 62(5):803-19. PubMed ID: 23291248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.
    Niranjan R
    Mol Neurobiol; 2014 Feb; 49(1):28-38. PubMed ID: 23783559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors].
    Takahashi R; Kawamata J; Takeuchi H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):885-7. PubMed ID: 20030238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease.
    Rideout HJ; Stefanis L
    Neurochem Res; 2014; 39(3):576-92. PubMed ID: 23729298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].
    Hattori N; Kubo S
    Rinsho Shinkeigaku; 2007 Nov; 47(11):774-8. PubMed ID: 18210796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the pathogenesis and genetics of Parkinson's disease.
    Mizuno Y; Hattori N; Kubo S; Sato S; Nishioka K; Hatano T; Tomiyama H; Funayama M; Machida Y; Mochizuki H
    Philos Trans R Soc Lond B Biol Sci; 2008 Jun; 363(1500):2215-27. PubMed ID: 18426756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetic Determinants of Parkinson's Disease Etiology.
    Kung PJ; Elsayed I; Reyes-Pérez P; Bandres-Ciga S
    J Parkinsons Dis; 2022; 12(s1):S13-S27. PubMed ID: 35367971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation is genetically implicated in Parkinson's disease.
    Dzamko N; Geczy CL; Halliday GM
    Neuroscience; 2015 Aug; 302():89-102. PubMed ID: 25450953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.